Paper39865817
Antiseizure Medications: Advancements, Challenges, and Prospects in Drug Development.
Ng YH and 6 others. Curr Neuropharmacol, 2025. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Antiseizure Medications: Advancements, Challenges, and Prospects in Drug Development. Papers, record 39865817. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39865817
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticonvulsants | Major topic |
| Drug Development | Major topic |
| Epilepsy | Major topic |
| Humans | |
| Animals |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GUP-2021-055 | Universiti Kebangsaan Malaysia | PubMed |
Source PubMed
References223
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31852003 | The Epidemiology of Epilepsy. | Neuroepidemiology | 2020 | https://conductscience.org/library/papers/31852003 | PubMed |
| 2 | 34122318 | The Effect of Anti-seizure Medications on the Propagation of Epileptic Activity: A Review. | Front Neurol | 2021 | https://conductscience.org/library/papers/34122318 | PubMed |
| 3 | 34145528 | The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond. | CNS Drugs | 2021 | https://conductscience.org/library/papers/34145528 | PubMed |
| 4 | 32077329 | Time to Start Calling Things by Their Own Names? The Case for Antiseizure Medicines. | Epilepsy Curr | 2020 | https://conductscience.org/library/papers/32077329 | PubMed |
| 5 | 27789949 | Managing drug-resistant epilepsy: challenges and solutions. | Neuropsychiatr Dis Treat | 2016 | https://conductscience.org/library/papers/27789949 | PubMed |
| 6 | 28931473 | Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. | Epilepsy Behav | 2017 | https://conductscience.org/library/papers/28931473 | PubMed |
| 7 | 33746731 | Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function - Implications for Potential Therapies. | Front Synaptic Neurosci | 2021 | https://conductscience.org/library/papers/33746731 | PubMed |
| 8 | 31129313 | Voltage-gated sodium channels: structures, functions, and molecular modeling. | Drug Discov Today | 2019 | https://conductscience.org/library/papers/31129313 | PubMed |
| 9 | 25848093 | Structural Basis for Pharmacology of Voltage-Gated Sodium and Calcium Channels. | Mol Pharmacol | 2015 | https://conductscience.org/library/papers/25848093 | PubMed |
| 10 | 26646477 | Voltage gated sodium channels as drug discovery targets. | Channels (Austin) | 2015 | https://conductscience.org/library/papers/26646477 | PubMed |
| 11 | 22473783 | Voltage-gated sodium channels at 60: structure, function and pathophysiology. | J Physiol | 2012 | https://conductscience.org/library/papers/22473783 | PubMed |
| 12 | 21743477 | The crystal structure of a voltage-gated sodium channel. | Nature | 2011 | https://conductscience.org/library/papers/21743477 | PubMed |
| 13 | 28258204 | Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants. | J Gen Physiol | 2017 | https://conductscience.org/library/papers/28258204 | PubMed |
| 14 | 26712848 | The hitchhiker's guide to the voltage-gated sodium channel galaxy. | J Gen Physiol | 2016 | https://conductscience.org/library/papers/26712848 | PubMed |
| 15 | 34416507 | Voltage gated sodium channel inhibitors as anticonvulsant drugs: A systematic review on recent developments and structure activity relationship studies. | Bioorg Chem | 2021 | https://conductscience.org/library/papers/34416507 | PubMed |
| 16 | 33713668 | Pharmacology of lacosamide: From its molecular mechanisms and pharmacokinetics to future therapeutic applications. | Life Sci | 2021 | https://conductscience.org/library/papers/33713668 | PubMed |
| 17 | 25616473 | Current understanding of the mechanism of action of the antiepileptic drug lacosamide. | Epilepsy Res | 2015 | https://conductscience.org/library/papers/25616473 | PubMed |
| 18 | 16608372 | Valproate as a mainstay of therapy for pediatric epilepsy. | Paediatr Drugs | 2006 | https://conductscience.org/library/papers/16608372 | PubMed |
| 19 | 20298965 | Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders. | Lancet Neurol | 2010 | https://conductscience.org/library/papers/20298965 | PubMed |
| 20 | 33236643 | The Role of the Persistent Sodium Current in Epilepsy. | Epilepsy Curr | 2021 | https://conductscience.org/library/papers/33236643 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42883852 | Network Pharmacology-Guided Identification of Orientin from Passiflora incarnata Reveals Neuroprotective Effects Against Glutamate-Induced Excitotoxicity Through Regulation of Calcium Homeostasis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42883852 | PubMed |
| 42852120 | Chronic dizziness: neuro-sensitization and psycho-sensitization. | Front Integr Neurosci | 2026 | https://conductscience.org/library/papers/42852120 | PubMed |
| 42809027 | Unraveling the role of FGF21 in epilepsy disease: mechanistic insights and therapeutic Potential. | Metab Brain Dis | 2026 | https://conductscience.org/library/papers/42809027 | PubMed |
| 42661020 | Bridging the Gap: Harnessing Phytochemical-Loaded Nanocarriers for Enhanced Epilepsy Treatment. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42661020 | PubMed |
| 42652171 | Targeting the Complement-Microglia Axis for Neuroprotection in Pediatric Epilepsy. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652171 | PubMed |
| 42627450 | Pharmacokinetics, Safety, and Dosing of Antiseizure Medications in Patients with Renal or Hepatic Impairment. | Clin Pharmacokinet | 2026 | https://conductscience.org/library/papers/42627450 | PubMed |
| 42524508 | Intranasal Biodegradable Nanomedicine for Epilepsy Management: Targeting the Brain Beyond the Blood-Brain Barrier. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42524508 | PubMed |
| 42460023 | Effect of high altitude on the pharmacokinetics and pharmacodynamics of valproate in epileptic rats. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42460023 | PubMed |
| 42148193 | Comparative Predictive Performance of Serum and Dose-Normalized Valproate Levels for Seizure Control in Adults With Epilepsy. | Cureus | 2026 | https://conductscience.org/library/papers/42148193 | PubMed |
| 42104025 | Thyroid-metabolic interactions in pediatric epilepsy: insights from central sensitivity indices and peripheral hormone markers. | Eur J Pediatr | 2026 | https://conductscience.org/library/papers/42104025 | PubMed |
| 41862818 | Treatment patterns and adverse events of antiseizure medications among adult patients with epilepsy: a single centre observational cross-sectional study in Northern Sri Lanka. | BMC Neurol | 2026 | https://conductscience.org/library/papers/41862818 | PubMed |
| 41832737 | Design, Synthesis, and Evaluation of Voltage-gated Sodium Channel Inhibitors as Anticonvulsant Agents. | Curr Neurovasc Res | 2026 | https://conductscience.org/library/papers/41832737 | PubMed |
| 41689598 | Evaluation of bone safety and antiseizure medications: a multi-source pharmacovigilance and Mendelian randomization analysis. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/41689598 | PubMed |
| 41290944 | Improved albumin binding properties of Isoguvacine upon esterification as characterized by biophysical and computational tools. | Sci Rep | 2025 | https://conductscience.org/library/papers/41290944 | PubMed |
| 41009365 | Special Issue: Molecular Research in Epilepsy and Epileptogenesis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009365 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39865817
GET https://conductscience.org/api/papers/v1/39865817/references?page=2